Opiela Shannon J, Adkins Becky
Sylvester Comprehensive Cancer Center; University of Miami Miller School of Medicine; Miami, FL USA.
Chimerism. 2010 Jul-Sep;1(1):36-8. doi: 10.4161/chim.1.1.12880.
Fetal and/or perinatal exposure to noninherited maternal antigens (NIMA) has been reported to induce NIMA-specific tolerance. This tolerant state is highly beneficial in transplantation settings; enhanced graft acceptance has been observed when transplanted tissues express NIMA. Reduction in severe graft-vs-host disease has also been noted when bone marrow grafts originate from donors exposed to NIMA in early life. However, there is emerging evidence that exposure to NIMA can alternatively lead to specific priming. The processes regulating tolerance versus priming to NIMA are poorly understood and probably multifactorial. Based on studies in both humans and mice, we propose that both the quality and the quantity of NIMA exposure will be found to be key determinants of these opposing outcomes.
据报道,胎儿和/或围产期暴露于非遗传母体抗原(NIMA)可诱导NIMA特异性耐受。这种耐受状态在移植环境中非常有益;当移植组织表达NIMA时,已观察到移植接受性增强。当骨髓移植来自早年暴露于NIMA的供体时,也注意到严重移植物抗宿主病有所减少。然而,越来越多的证据表明,暴露于NIMA也可能导致特异性致敏。调节对NIMA耐受与致敏的过程了解甚少,可能是多因素的。基于对人类和小鼠的研究,我们提出,NIMA暴露的质量和数量将被发现是这些相反结果的关键决定因素。